{"id":788703,"date":"2022-05-24T20:00:18","date_gmt":"2022-05-24T18:00:18","guid":{"rendered":"https:\/\/bebeez.it\/non-categorizzato\/cosette-pharmaceuticals-and-alembic-pharmaceuticals-limited-announce-the-approval-and-launch-of-a-national-brand-equivalent-nbe-of-abreva-docosanol-cream-10-including-the-first-approval-in-t\/"},"modified":"2023-07-11T12:11:14","modified_gmt":"2023-07-11T10:11:14","slug":"cosette-pharmaceuticals-and-alembic-pharmaceuticals-limited-announce-the-approval-and-launch-of-a-national-brand-equivalent-nbe-of-abreva-docosanol-cream-10-including-the-first-approval-in-t-2","status":"publish","type":"post","link":"https:\/\/bebeez.it\/en\/private-capital-in-north-america\/cosette-pharmaceuticals-and-alembic-pharmaceuticals-limited-announce-the-approval-and-launch-of-a-national-brand-equivalent-nbe-of-abreva-docosanol-cream-10-including-the-first-approval-in-t-2\/","title":{"rendered":"Cosette Pharmaceuticals and Alembic Pharmaceuticals Limited Announce the Approval and Launch of a National Brand Equivalent (NBE) of Abreva\u00ae (Docosanol Cream 10%) Including the First Approval in the Pump Format"},"content":{"rendered":"BRIDGEWATER, N.J. & VADODARA, India--(BUSINESS WIRE)--#abreva--Cosette Pharmaceuticals, Inc (\"Cosette\"), in collaboration with Aleor Dermaceuticals, a wholly owned subsidiary of Alembic Pharmaceuticals (\u201cAlembic\u201d; BSE: 533573), announced that the U.S. Food and Drug Administration (FDA) has approved the Abbreviated New Drug Application (ANDA) for an NBE version of Abreva\u00ae (Docosanol cream 10%) in a 2 gm tube and pump formats. Shipments of the product will begin imminently.\n\n\n\nApurva Saraf, CEO of Cosette Pharma and Pranav Amin, MD of Alembic Pharma stated, \"This approval and launch highlights our ability to successfully partner and bring important complex products to market. We look forward to launching this Private Label, Over-the-
Abbonati<\/a> o Accedi<\/a> per leggere il resto di questo contenuto.<\/div><\/div>","protected":false},"excerpt":{"rendered":"

BRIDGEWATER, N.J. & VADODARA, India–(BUSINESS WIRE)–#abreva–Cosette Pharmaceuticals, Inc (“Cosette”), in collaboration with Aleor Dermaceuticals, a wholly owned subsidiary of Alembic Pharmaceuticals (\u201cAlembic\u201d; BSE: 533573), announced that the U.S. Food and Drug Administration (FDA) has approved the Abbreviated New Drug Application (ANDA) for an NBE version of Abreva\u00ae (Docosanol cream 10%) in a 2 gm tube […]<\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[49625],"tags":[],"settori":[],"slider_categorie_and_home_page":[],"class_list":["post-788703","post","type-post","status-publish","format-standard","hentry","category-private-capital-in-north-america"],"acf":[],"yoast_head":"\nCosette Pharmaceuticals and Alembic Pharmaceuticals Limited Announce the Approval and Launch of a National Brand Equivalent (NBE) of Abreva\u00ae (Docosanol Cream 10%) Including the First Approval in the Pump Format - BeBeez<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/bebeez.it\/en\/private-capital-in-north-america\/cosette-pharmaceuticals-and-alembic-pharmaceuticals-limited-announce-the-approval-and-launch-of-a-national-brand-equivalent-nbe-of-abreva-docosanol-cream-10-including-the-first-approval-in-t-2\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Cosette Pharmaceuticals and Alembic Pharmaceuticals Limited Announce the Approval and Launch of a National Brand Equivalent (NBE) of Abreva\u00ae (Docosanol Cream 10%) Including the First Approval in the Pump Format - BeBeez\" \/>\n<meta property=\"og:description\" content=\"BRIDGEWATER, N.J. & VADODARA, India--(BUSINESS WIRE)--#abreva--Cosette Pharmaceuticals, Inc ("Cosette"), in collaboration with Aleor Dermaceuticals, a wholly owned subsidiary of Alembic Pharmaceuticals (\u201cAlembic\u201d; BSE: 533573), announced that the U.S. Food and Drug Administration (FDA) has approved the Abbreviated New Drug Application (ANDA) for an NBE version of Abreva\u00ae (Docosanol cream 10%) in a 2 gm tube […]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/bebeez.it\/en\/private-capital-in-north-america\/cosette-pharmaceuticals-and-alembic-pharmaceuticals-limited-announce-the-approval-and-launch-of-a-national-brand-equivalent-nbe-of-abreva-docosanol-cream-10-including-the-first-approval-in-t-2\/\" \/>\n<meta property=\"og:site_name\" content=\"BeBeez\" \/>\n<meta property=\"article:published_time\" content=\"2022-05-24T18:00:18+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2023-07-11T10:11:14+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/bebeez.it\/wp-content\/uploads\/2019\/10\/be-beez-logo-x2.png\" \/>\n\t<meta property=\"og:image:width\" content=\"683\" \/>\n\t<meta property=\"og:image:height\" content=\"242\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"olomaster\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"olomaster\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/bebeez.it\/en\/private-capital-in-north-america\/cosette-pharmaceuticals-and-alembic-pharmaceuticals-limited-announce-the-approval-and-launch-of-a-national-brand-equivalent-nbe-of-abreva-docosanol-cream-10-including-the-first-approval-in-t-2\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/bebeez.it\/en\/private-capital-in-north-america\/cosette-pharmaceuticals-and-alembic-pharmaceuticals-limited-announce-the-approval-and-launch-of-a-national-brand-equivalent-nbe-of-abreva-docosanol-cream-10-including-the-first-approval-in-t-2\/\"},\"author\":{\"name\":\"olomaster\",\"@id\":\"https:\/\/15.161.165.86\/#\/schema\/person\/f3523ef027b0af56aa28725439cc9518\"},\"headline\":\"Cosette Pharmaceuticals and Alembic Pharmaceuticals Limited Announce the Approval and Launch of a National Brand Equivalent (NBE) of Abreva\u00ae (Docosanol Cream 10%) Including the First Approval in the Pump Format\",\"datePublished\":\"2022-05-24T18:00:18+00:00\",\"dateModified\":\"2023-07-11T10:11:14+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/bebeez.it\/en\/private-capital-in-north-america\/cosette-pharmaceuticals-and-alembic-pharmaceuticals-limited-announce-the-approval-and-launch-of-a-national-brand-equivalent-nbe-of-abreva-docosanol-cream-10-including-the-first-approval-in-t-2\/\"},\"wordCount\":395,\"publisher\":{\"@id\":\"https:\/\/15.161.165.86\/#organization\"},\"articleSection\":[\"Private capital in North America\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/bebeez.it\/en\/private-capital-in-north-america\/cosette-pharmaceuticals-and-alembic-pharmaceuticals-limited-announce-the-approval-and-launch-of-a-national-brand-equivalent-nbe-of-abreva-docosanol-cream-10-including-the-first-approval-in-t-2\/\",\"url\":\"https:\/\/bebeez.it\/en\/private-capital-in-north-america\/cosette-pharmaceuticals-and-alembic-pharmaceuticals-limited-announce-the-approval-and-launch-of-a-national-brand-equivalent-nbe-of-abreva-docosanol-cream-10-including-the-first-approval-in-t-2\/\",\"name\":\"Cosette Pharmaceuticals and Alembic Pharmaceuticals Limited Announce the Approval and Launch of a National Brand Equivalent (NBE) of Abreva\u00ae (Docosanol Cream 10%) Including the First Approval in the Pump Format - BeBeez\",\"isPartOf\":{\"@id\":\"https:\/\/15.161.165.86\/#website\"},\"datePublished\":\"2022-05-24T18:00:18+00:00\",\"dateModified\":\"2023-07-11T10:11:14+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/bebeez.it\/en\/private-capital-in-north-america\/cosette-pharmaceuticals-and-alembic-pharmaceuticals-limited-announce-the-approval-and-launch-of-a-national-brand-equivalent-nbe-of-abreva-docosanol-cream-10-including-the-first-approval-in-t-2\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/bebeez.it\/en\/private-capital-in-north-america\/cosette-pharmaceuticals-and-alembic-pharmaceuticals-limited-announce-the-approval-and-launch-of-a-national-brand-equivalent-nbe-of-abreva-docosanol-cream-10-including-the-first-approval-in-t-2\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/bebeez.it\/en\/private-capital-in-north-america\/cosette-pharmaceuticals-and-alembic-pharmaceuticals-limited-announce-the-approval-and-launch-of-a-national-brand-equivalent-nbe-of-abreva-docosanol-cream-10-including-the-first-approval-in-t-2\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/bebeez.it\/en\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Cosette Pharmaceuticals and Alembic Pharmaceuticals Limited Announce the Approval and Launch of a National Brand Equivalent (NBE) of Abreva\u00ae (Docosanol Cream 10%) Including the First Approval in the Pump Format\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/15.161.165.86\/#website\",\"url\":\"https:\/\/15.161.165.86\/\",\"name\":\"BeBeez\",\"description\":\"BeBeez\",\"publisher\":{\"@id\":\"https:\/\/15.161.165.86\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/15.161.165.86\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/15.161.165.86\/#organization\",\"name\":\"BeBeez\",\"url\":\"https:\/\/15.161.165.86\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/15.161.165.86\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/bebeez.it\/wp-content\/uploads\/2019\/10\/be-beez-logo.png\",\"contentUrl\":\"https:\/\/bebeez.it\/wp-content\/uploads\/2019\/10\/be-beez-logo.png\",\"width\":309,\"height\":122,\"caption\":\"BeBeez\"},\"image\":{\"@id\":\"https:\/\/15.161.165.86\/#\/schema\/logo\/image\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\/\/15.161.165.86\/#\/schema\/person\/f3523ef027b0af56aa28725439cc9518\",\"name\":\"olomaster\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/15.161.165.86\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/f27d32333d7dec7da2843c6d51349029304daff2c6c3fb07164f8de234678661?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/f27d32333d7dec7da2843c6d51349029304daff2c6c3fb07164f8de234678661?s=96&d=mm&r=g\",\"caption\":\"olomaster\"},\"url\":\"https:\/\/bebeez.it\/en\/author\/olomaster\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Cosette Pharmaceuticals and Alembic Pharmaceuticals Limited Announce the Approval and Launch of a National Brand Equivalent (NBE) of Abreva\u00ae (Docosanol Cream 10%) Including the First Approval in the Pump Format - BeBeez","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/bebeez.it\/en\/private-capital-in-north-america\/cosette-pharmaceuticals-and-alembic-pharmaceuticals-limited-announce-the-approval-and-launch-of-a-national-brand-equivalent-nbe-of-abreva-docosanol-cream-10-including-the-first-approval-in-t-2\/","og_locale":"en_US","og_type":"article","og_title":"Cosette Pharmaceuticals and Alembic Pharmaceuticals Limited Announce the Approval and Launch of a National Brand Equivalent (NBE) of Abreva\u00ae (Docosanol Cream 10%) Including the First Approval in the Pump Format - BeBeez","og_description":"BRIDGEWATER, N.J. & VADODARA, India--(BUSINESS WIRE)--#abreva--Cosette Pharmaceuticals, Inc (\"Cosette\"), in collaboration with Aleor Dermaceuticals, a wholly owned subsidiary of Alembic Pharmaceuticals (\u201cAlembic\u201d; BSE: 533573), announced that the U.S. Food and Drug Administration (FDA) has approved the Abbreviated New Drug Application (ANDA) for an NBE version of Abreva\u00ae (Docosanol cream 10%) in a 2 gm tube […]","og_url":"https:\/\/bebeez.it\/en\/private-capital-in-north-america\/cosette-pharmaceuticals-and-alembic-pharmaceuticals-limited-announce-the-approval-and-launch-of-a-national-brand-equivalent-nbe-of-abreva-docosanol-cream-10-including-the-first-approval-in-t-2\/","og_site_name":"BeBeez","article_published_time":"2022-05-24T18:00:18+00:00","article_modified_time":"2023-07-11T10:11:14+00:00","og_image":[{"width":683,"height":242,"url":"https:\/\/bebeez.it\/wp-content\/uploads\/2019\/10\/be-beez-logo-x2.png","type":"image\/png"}],"author":"olomaster","twitter_card":"summary_large_image","twitter_misc":{"Written by":"olomaster","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/bebeez.it\/en\/private-capital-in-north-america\/cosette-pharmaceuticals-and-alembic-pharmaceuticals-limited-announce-the-approval-and-launch-of-a-national-brand-equivalent-nbe-of-abreva-docosanol-cream-10-including-the-first-approval-in-t-2\/#article","isPartOf":{"@id":"https:\/\/bebeez.it\/en\/private-capital-in-north-america\/cosette-pharmaceuticals-and-alembic-pharmaceuticals-limited-announce-the-approval-and-launch-of-a-national-brand-equivalent-nbe-of-abreva-docosanol-cream-10-including-the-first-approval-in-t-2\/"},"author":{"name":"olomaster","@id":"https:\/\/15.161.165.86\/#\/schema\/person\/f3523ef027b0af56aa28725439cc9518"},"headline":"Cosette Pharmaceuticals and Alembic Pharmaceuticals Limited Announce the Approval and Launch of a National Brand Equivalent (NBE) of Abreva\u00ae (Docosanol Cream 10%) Including the First Approval in the Pump Format","datePublished":"2022-05-24T18:00:18+00:00","dateModified":"2023-07-11T10:11:14+00:00","mainEntityOfPage":{"@id":"https:\/\/bebeez.it\/en\/private-capital-in-north-america\/cosette-pharmaceuticals-and-alembic-pharmaceuticals-limited-announce-the-approval-and-launch-of-a-national-brand-equivalent-nbe-of-abreva-docosanol-cream-10-including-the-first-approval-in-t-2\/"},"wordCount":395,"publisher":{"@id":"https:\/\/15.161.165.86\/#organization"},"articleSection":["Private capital in North America"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/bebeez.it\/en\/private-capital-in-north-america\/cosette-pharmaceuticals-and-alembic-pharmaceuticals-limited-announce-the-approval-and-launch-of-a-national-brand-equivalent-nbe-of-abreva-docosanol-cream-10-including-the-first-approval-in-t-2\/","url":"https:\/\/bebeez.it\/en\/private-capital-in-north-america\/cosette-pharmaceuticals-and-alembic-pharmaceuticals-limited-announce-the-approval-and-launch-of-a-national-brand-equivalent-nbe-of-abreva-docosanol-cream-10-including-the-first-approval-in-t-2\/","name":"Cosette Pharmaceuticals and Alembic Pharmaceuticals Limited Announce the Approval and Launch of a National Brand Equivalent (NBE) of Abreva\u00ae (Docosanol Cream 10%) Including the First Approval in the Pump Format - BeBeez","isPartOf":{"@id":"https:\/\/15.161.165.86\/#website"},"datePublished":"2022-05-24T18:00:18+00:00","dateModified":"2023-07-11T10:11:14+00:00","breadcrumb":{"@id":"https:\/\/bebeez.it\/en\/private-capital-in-north-america\/cosette-pharmaceuticals-and-alembic-pharmaceuticals-limited-announce-the-approval-and-launch-of-a-national-brand-equivalent-nbe-of-abreva-docosanol-cream-10-including-the-first-approval-in-t-2\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/bebeez.it\/en\/private-capital-in-north-america\/cosette-pharmaceuticals-and-alembic-pharmaceuticals-limited-announce-the-approval-and-launch-of-a-national-brand-equivalent-nbe-of-abreva-docosanol-cream-10-including-the-first-approval-in-t-2\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/bebeez.it\/en\/private-capital-in-north-america\/cosette-pharmaceuticals-and-alembic-pharmaceuticals-limited-announce-the-approval-and-launch-of-a-national-brand-equivalent-nbe-of-abreva-docosanol-cream-10-including-the-first-approval-in-t-2\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/bebeez.it\/en\/"},{"@type":"ListItem","position":2,"name":"Cosette Pharmaceuticals and Alembic Pharmaceuticals Limited Announce the Approval and Launch of a National Brand Equivalent (NBE) of Abreva\u00ae (Docosanol Cream 10%) Including the First Approval in the Pump Format"}]},{"@type":"WebSite","@id":"https:\/\/15.161.165.86\/#website","url":"https:\/\/15.161.165.86\/","name":"BeBeez","description":"BeBeez","publisher":{"@id":"https:\/\/15.161.165.86\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/15.161.165.86\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/15.161.165.86\/#organization","name":"BeBeez","url":"https:\/\/15.161.165.86\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/15.161.165.86\/#\/schema\/logo\/image\/","url":"https:\/\/bebeez.it\/wp-content\/uploads\/2019\/10\/be-beez-logo.png","contentUrl":"https:\/\/bebeez.it\/wp-content\/uploads\/2019\/10\/be-beez-logo.png","width":309,"height":122,"caption":"BeBeez"},"image":{"@id":"https:\/\/15.161.165.86\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/15.161.165.86\/#\/schema\/person\/f3523ef027b0af56aa28725439cc9518","name":"olomaster","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/15.161.165.86\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/f27d32333d7dec7da2843c6d51349029304daff2c6c3fb07164f8de234678661?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/f27d32333d7dec7da2843c6d51349029304daff2c6c3fb07164f8de234678661?s=96&d=mm&r=g","caption":"olomaster"},"url":"https:\/\/bebeez.it\/en\/author\/olomaster\/"}]}},"_links":{"self":[{"href":"https:\/\/bebeez.it\/en\/wp-json\/wp\/v2\/posts\/788703","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/bebeez.it\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/bebeez.it\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/bebeez.it\/en\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/bebeez.it\/en\/wp-json\/wp\/v2\/comments?post=788703"}],"version-history":[{"count":1,"href":"https:\/\/bebeez.it\/en\/wp-json\/wp\/v2\/posts\/788703\/revisions"}],"predecessor-version":[{"id":891132,"href":"https:\/\/bebeez.it\/en\/wp-json\/wp\/v2\/posts\/788703\/revisions\/891132"}],"wp:attachment":[{"href":"https:\/\/bebeez.it\/en\/wp-json\/wp\/v2\/media?parent=788703"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/bebeez.it\/en\/wp-json\/wp\/v2\/categories?post=788703"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/bebeez.it\/en\/wp-json\/wp\/v2\/tags?post=788703"},{"taxonomy":"settori","embeddable":true,"href":"https:\/\/bebeez.it\/en\/wp-json\/wp\/v2\/settori?post=788703"},{"taxonomy":"slider_categorie_and_home_page","embeddable":true,"href":"https:\/\/bebeez.it\/en\/wp-json\/wp\/v2\/slider_categorie_and_home_page?post=788703"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}